In a press release today, Immunex Corporation revealed that a new study shows the controversial rheumatoid arthritis medication Enbrel is safe and effective. According to the drug maker, of 629 patients using Enbrel for five years, 70 percent responded successfully to the drug. Enbrel also seemed to be well tolerated